The Pursuit of "Best" Anticoagulant for Cancer-Associated Thrombosis: Are We There Yet? | JACC CardioOncol;6(1): 114-116, 2024 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The Pursuit of "Best" Anticoagulant for Cancer-Associated Thrombosis: Are We There Yet?

Wang, Tzu-Fei; Connors, Jean M.

Affiliation

Wang TF; Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Connors JM; Division of Hematology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

JACC CardioOncol ; 6(1): 114-116, 2024 Feb.

Article in En | MEDLINE | ID: mdl-38510294

Key words

anticoagulation; direct oral anticoagulant; low molecular weight heparin; neoplasia; venous thromboembolism

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC CardioOncol / JACC. CardioOncology Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC CardioOncol / JACC. CardioOncology Year: 2024 Document type: Article Affiliation country: Country of publication: